Table 4 Psychopharmacological treatment before admission to SPDC, during SPDC stay and at discharge. Percentages are calculated on patients under treatment at admission, during hospital stay and at discharge.
Type of drug | At admission n (%) | In SPDC n (%) | At discharge n (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Overall | Females | Males | Overall | Females | Males | Overall | Females | Males |
Benzodiazepine | 960 (58.6) | 513 (42.3)* | 447 (35.5)* | 1927 (79.3) | 964 (79.4) | 963 (76.6) | 1604 (68.0) | 795 (65.5) | 809 (64.3) |
Atypical antipsychotic | 700 (42.7) | 321 (26.4)†| 379 (30.1)†| 1215 (50.0) | 571 (47.0)†| 644 (51.2)†| 1222 (51.8) | 577 (47.5) | 645 (51.3) |
Conventional antipsychotic | 690 (42.1) | 316 (26.6)†| 374 (29.7)†| 1268 (52.2) | 575 (47.4)* | 693 (55.1)* | 1046 (44.4) | 483 (39.8)†| 563 (44.8)†|
Antidepressant | 591 (36.1) | 361 (29.7)* | 230 (18.3)* | 808 (33.3) | 476 (39.2)* | 332 (26.4)* | 795 (33.7) | 464 (38.2)* | 331 (26.3)* |
Mood stabilizer | 509 (31.1) | 263 (21.7) | 246 (19.6) | 764 (31.5) | 391 (32.2) | 373 (29.7) | 774 (32.8) | 392 (32.3) | 382 (30.4) |
Anticholinergic | 131 (8.0) | 53 (4.4)†| 78 (6.2)†| 301 (12.4) | 119 (9.8)* | 182 (14.5)* | 261 (11.1) | 107 (8.8)§S | 154 (12.2)§S |
Other | 67 (4.1) | 28 (2.3)†| 15 (1.2)†| 215 (8.9) | 92 (7.6)* | 55 (4.4)* | 101 (4.2) | 43 (3.5)†| 24 (1.9)†|
Total no. of patients on treatment | 1638 (66.3) | 825 (68.0) | 813 (64.6) | 2429 (98.3) | 1197 (98.6) | 1232 (97.8) | 2358 (95.4) | 1161 (95.6) | 1197 (95.2) |
(% of total PERSEO population) | Â | Â | Â | Â | Â | Â | Â | Â | Â |